Cyclops, Lda is a Coimbra company, founded in 2022 and registered at the Edifício Pedro Nunes, that trades enriched isotope materials used to make radiopharmaceuticals. In September 2025 it won a Finnish hospital contract: Servica Oy, buying for Kuopio University Hospital’s clinical nuclear-medicine unit, awarded Cyclops the supply of enriched zinc oxide (ZnO-68) worth €175,680.
The Finnish award notice describes ZnO-68 as a material used in the production of a radiopharmaceutical isotope; enriched zinc-68 is the target material used to produce gallium-68 in cyclotrons, a positron emitter used in PET imaging. The buyer of record is Servica Oy, the Kuopio-based procurement company that tendered on behalf of the Wellbeing Services County of Northern Savo, and the end user is Kuopio University Hospital’s Clinical Physiology and Clinical Nuclear Medicine unit.
Cyclops was the only tenderer named in the award, concluded on 26 September 2025 and published on Tenders Electronic Daily on 14 October 2025 with a value of €175,680. The company itself is small: incorporated in June 2022 with €2,000 of share capital and registered for the wholesale of chemical products at the Edifício Pedro Nunes in Coimbra.
Nuclear-medicine supply chains are specialised, low-volume and published on TED when public hospitals buy. A three-year-old Coimbra company winning a Finnish university-hospital contract shows the route open to Portuguese niche suppliers: specification-driven tenders in which the buyer judges the material and the delivery terms rather than the size of the supplier.
14 October 2025: Servica Oy publishes the award of the ZnO-68 supply to Cyclops, Lda (€175,680, TED 674750-2025). NorthSouth HQ tracks Portuguese winners of Nordic public contracts in its TED award analysis.
Status: Compiled from public sources · Last verified: · Update this profile
Work at Cyclops? Send corrections or additions. Every update is checked before it is published; submissions are reviewed within a few working days.
Fractio helps Portuguese companies navigate Nordic market entry, regulatory requirements, partnership development and Nordic market dynamics.
Talk to Fractio →